Stefania Toneguzzi

1.3k total citations
26 papers, 1.1k citations indexed

About

Stefania Toneguzzi is a scholar working on Oncology, Rheumatology and Immunology and Allergy. According to data from OpenAlex, Stefania Toneguzzi has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Rheumatology and 9 papers in Immunology and Allergy. Recurrent topics in Stefania Toneguzzi's work include Chemokine receptors and signaling (10 papers), Cell Adhesion Molecules Research (9 papers) and Osteoarthritis Treatment and Mechanisms (8 papers). Stefania Toneguzzi is often cited by papers focused on Chemokine receptors and signaling (10 papers), Cell Adhesion Molecules Research (9 papers) and Osteoarthritis Treatment and Mechanisms (8 papers). Stefania Toneguzzi collaborates with scholars based in Italy and United States. Stefania Toneguzzi's co-authors include Gina Lisignoli, A. Piacentini, Francesco Grassi, Andrea Facchini, Sandra Cristino, Carola Cavallo, A. Facchini, G Gualtieri, Nicoletta Zini and A. Ferruzzi and has published in prestigious journals such as Biomaterials, European Journal of Immunology and Journal of Cellular Physiology.

In The Last Decade

Stefania Toneguzzi

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefania Toneguzzi Italy 16 400 375 335 187 152 26 1.1k
Lynda O’Rear United States 15 231 0.6× 365 1.0× 593 1.8× 81 0.4× 170 1.1× 22 1.4k
T. Krieg Germany 20 185 0.5× 249 0.7× 460 1.4× 251 1.3× 233 1.5× 53 1.8k
Kunihiro Masuda Japan 18 366 0.9× 439 1.2× 343 1.0× 77 0.4× 80 0.5× 56 1.3k
Catherine J. Fliszar United States 12 570 1.4× 196 0.5× 524 1.6× 130 0.7× 198 1.3× 12 1.8k
James R. Dasch United States 19 199 0.5× 171 0.5× 625 1.9× 395 2.1× 175 1.2× 28 1.5k
Janet M. Kerr United States 14 254 0.6× 719 1.9× 762 2.3× 93 0.5× 72 0.5× 16 1.7k
Wojciech J. Grzesik United States 18 196 0.5× 424 1.1× 721 2.2× 52 0.3× 194 1.3× 26 1.7k
Atsuhiko Hikita Japan 22 430 1.1× 419 1.1× 737 2.2× 145 0.8× 98 0.6× 74 1.7k
Therese Standal Norway 22 702 1.8× 284 0.8× 846 2.5× 257 1.4× 57 0.4× 47 1.7k
Masahiko Terajima United States 22 175 0.4× 255 0.7× 595 1.8× 49 0.3× 94 0.6× 59 1.4k

Countries citing papers authored by Stefania Toneguzzi

Since Specialization
Citations

This map shows the geographic impact of Stefania Toneguzzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Toneguzzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Toneguzzi more than expected).

Fields of papers citing papers by Stefania Toneguzzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefania Toneguzzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Toneguzzi. The network helps show where Stefania Toneguzzi may publish in the future.

Co-authorship network of co-authors of Stefania Toneguzzi

This figure shows the co-authorship network connecting the top 25 collaborators of Stefania Toneguzzi. A scholar is included among the top collaborators of Stefania Toneguzzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefania Toneguzzi. Stefania Toneguzzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lisignoli, Gina, Stefania Toneguzzi, A. Piacentini, et al.. (2005). CXCL12 (SDF‐1) and CXCL13 (BCA‐1) chemokines significantly induce proliferation and collagen type I expression in osteoblasts from osteoarthritis patients. Journal of Cellular Physiology. 206(1). 78–85. 74 indexed citations
2.
Lisignoli, Gina, Sandra Cristino, A. Piacentini, et al.. (2005). Cellular and molecular events during chondrogenesis of human mesenchymal stromal cells grown in a three-dimensional hyaluronan based scaffold. Biomaterials. 26(28). 5677–5686. 103 indexed citations
3.
Lisignoli, Gina, Sandra Cristino, Stefania Toneguzzi, et al.. (2004). IL1β and TNFα differently modulate CXCL13 chemokine in stromal cells and osteoblasts isolated from osteoarthritis patients: evidence of changes associated to cell maturation. Experimental Gerontology. 39(4). 659–665. 36 indexed citations
4.
Grassi, Francesco, A. Piacentini, Sandra Cristino, et al.. (2004). Inhibition of CD95 apoptotic signaling by interferon‐γ in human osteoarthritic chondrocytes is associated with increased expression of FLICE inhibitory protein. Arthritis & Rheumatism. 50(2). 498–506. 12 indexed citations
5.
Lisignoli, Gina, A. Piacentini, Stefania Toneguzzi, et al.. (2003). Age-associated changes in functional response to CXCR3 and CXCR5 chemokine receptors in human osteoblasts. Biogerontology. 4(5). 309–317. 11 indexed citations
6.
Lisignoli, Gina, Stefania Toneguzzi, A. Piacentini, et al.. (2003). Recruitment and proliferation of T lymphocytes is supported by IFNγ‐ and TNFα‐activated human osteoblasts: Involvement of CD54 (ICAM‐1) and CD106 (VCAM‐1) adhesion molecules and CXCR3 chemokine receptor. Journal of Cellular Physiology. 198(3). 388–398. 28 indexed citations
7.
Grassi, Francesco, A. Piacentini, Sandra Cristino, et al.. (2003). Human osteoclasts express different CXC chemokines depending on cell culture substrate: molecular and immunocytochemical evidence of high levels of CXCL10 and CXCL12. Histochemistry and Cell Biology. 120(5). 391–400. 64 indexed citations
8.
Grassi, Francesco, Sandra Cristino, Stefania Toneguzzi, et al.. (2003). CXCL12 chemokine up‐regulates bone resorption and MMP‐9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients. Journal of Cellular Physiology. 199(2). 244–251. 109 indexed citations
9.
Lisignoli, Gina, Stefania Toneguzzi, Francesco Grassi, et al.. (2002). DIFFERENT CHEMOKINES ARE EXPRESSED IN HUMAN ARTHRITIC BONE BIOPSIES: IFN-γ AND IL-6 DIFFERENTLY MODULATE IL-8, MCP-1 AND RANTES PRODUCTION BY ARTHRITIC OSTEOBLASTS. Cytokine. 20(5). 231–238. 65 indexed citations
10.
Lisignoli, Gina, Milena Fini, Gianluca Giavaresi, et al.. (2002). Osteogenesis of large segmental radius defects enhanced by basic fibroblast growth factor activated bone marrow stromal cells grown on non-woven hyaluronic acid-based polymer scaffold. Biomaterials. 23(4). 1043–1051. 72 indexed citations
11.
Lisignoli, Gina, Stefania Toneguzzi, A. Piacentini, et al.. (2002). Human osteoblasts express functional CXC chemokine receptors 3 and 5: Activation by their ligands, CXCL10 and CXCL13, significantly induces alkaline phosphatase and β‐N‐acetylhexosaminidase release. Journal of Cellular Physiology. 194(1). 71–79. 52 indexed citations
12.
Lisignoli, Gina, Francesco Grassi, Nicoletta Zini, et al.. (2001). Anti-Fas-induced apoptosis in chondrocytes reduced by hyaluronan: Evidence for CD44 and CD54 (intercellular adhesion molecule 1) involvement. Arthritis & Rheumatism. 44(8). 1800–1807. 112 indexed citations
13.
Lisignoli, Gina, A. Piacentini, Stefania Toneguzzi, et al.. (2000). Osteoblasts and stromal cells isolated from femora in rheumatoid arthritis (RA) and osteoarthritis (OA) patients express IL-11, leukaemia inhibitory factor and oncostatin M. Clinical & Experimental Immunology. 119(2). 346–353. 48 indexed citations
14.
Lisignoli, Gina, Stefania Toneguzzi, A. Piacentini, et al.. (1999). Proinflammatory cytokines and chemokine production and expression by human osteoblasts isolated from patients with rheumatoid arthritis and osteoarthritis.. PubMed. 26(4). 791–9. 90 indexed citations
15.
Degrassi, A., Maria Chiara Monaco, Gina Lisignoli, et al.. (1998). Cell cycle synchronization of FRTL5 cells. A physiological model system.. PubMed. 17(4). 527–32. 9 indexed citations
16.
Grigolo, Brunella, Gina Lisignoli, Stefania Toneguzzi, Ilaria Mazzetti, & Andrea Facchini. (1998). Copper/zinc superoxide dismutase expression by different human osteosarcoma cell lines.. PubMed. 18(2A). 1175–80. 16 indexed citations
17.
Lisignoli, Gina, Chiara Pozzi, Stefania Toneguzzi, et al.. (1998). Different pattern of cytokine production and mRNA expression by lymphoid and non-lymphoid cells isolated from human palatine tonsil. International Journal of Clinical & Laboratory Research. 28(1). 23–28. 4 indexed citations
18.
Honorati, M.C., Rosa Maria Borzı̀, Paolo Dolzani, Stefania Toneguzzi, & A. Facchini. (1997). Distribution of IgG subclasses after anti-hepatitis B virus immunization with a recombinant vaccine. International Journal of Clinical & Laboratory Research. 27(2-4). 202–206. 10 indexed citations
19.
Lisignoli, Gina, Maria Chiara Monaco, Andrea Facchini, et al.. (1996). In vitro cultured stromal cells from human tonsils display a distinct phenotype and induce B cell adhesion and proliferation. European Journal of Immunology. 26(1). 17–27. 25 indexed citations
20.
Lisignoli, Gina, et al.. (1993). In vitroimmunotoxicity of ±2′-deoxy-3′-thiacytidine, a new and-HIV agent. Clinical & Experimental Immunology. 92(3). 455–459. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026